As shown, shRNA-induced silencing or CRISPR/Cas9-induced KO of YME1L led to dramatic Gαi1 mRNA (Fig. 2C) and protein (Fig. 2D) downregulation in P1 primary glioma cells. The gene discussed is YME1L1; the disease is central nervous system cancer.